Role of Oncogenes and Tumor Suppressors in Metabolic Reprogramming and Cancer Therapeutics: A Review
Journal Title: Journal of Cancer and Tumor International - Year 2016, Vol 4, Issue 4
Abstract
Recently there has been a renewed interest on the signaling pathways and metabolic changes in cancer cells. It is well known that there are several oncogenes and tumor suppressors that affect cancer metabolism and re-engineer it for better growth and survival. The best description of tumor metabolism is the Warburg effect, which shifts from ATP production through oxidative phosphorylation to ATP production through glycolysis, even in the presence of oxygen. The Warburg effect is controlled by oncogenes—c-Myc, Kras, P1K/AKT/mTOR pathway—and tumor suppressors—p53, LKB1/AMPK, PTEN, and RB. Studies on oncogenes and tumor suppressors suggest potential therapeutic strategies. The oncogene Kras promotes increased glucose uptake, glycolytic flux and ribose biogenesis, and mediates reprogramming of glutamine metabolism by changes in gene expression. The tumor suppressor p53 promotes the expression of antioxidant proteins that regulate oxidative stress and glucose metabolism. The LKB1/AMPK agonists have potential to be anticancer drugs, as patients treated by metformin for diabetes had a lower incidence of cancer. Discovering the mechanism by which oncogenes and tumor suppressors regulate metabolism will allow for designing treatment strategies. This review discusses how several oncogenes and tumor suppressors regulate cellular metabolism, and the current therapeutic findings.
Authors and Affiliations
Muhammad Azharuddin, David Sharon
Gastric Cancer in Cameroon: Epidemiological Profile and Histopathological Appearance of 574 Cases
Objective: To describe the epidemiological and histopathological aspects of stomach cancer in Cameroon. Materials and Methods: This was a retrospective, descriptive study of histologically confirmed stomach cancers recru...
Symptoms Burden, Quality of Life and Its Determinant Factors in Advanced Lung Cancer Patients
Aims: To assess in advanced lung cancer patients’, reported symptoms burden, their QOL, and to identify determinant factors associated with their QOL in 2 healthcare departments. Study Design: A cross sectional study. Pl...
A Rare Case Report of a Metastatic Tumor of the Spermatic Cord Arising from Pancreatic Cancer
A 60-year-old patient complaining of pain and elevation of the right scrotal contents, who had been treated for pancreatic cancer, was suspected of having spermatic cord tumor. He underwent high orchiectomy for pain mana...
Analysis of Orthopedic Surgery for Long Bone Metastases and Pathologic Fractures
The study made a retrospective analysis of treatment outcomes in 105 patients subjected to 128 surgical interventions for metastatic involvement of long tubular bones. Endoprosthetic replacement of large joints (40.2%) a...
Mandibular Non-Hodgkin’s Lymphoma Mimicking as Dentoalveolar Abscess - A Rare Case Report
Mandible remains a site of swelling for number of diseases including infection, cyst, and tumors. A few rare lesions without any pathognomic and radiological features may cause diagnostic predicament. Diffuse large B-cel...